RSS-Feed abonnieren

DOI: 10.1055/s-0045-1812070
Timing of the Final Nocturnal Meal and Hypoglycemia Risk in Fasting Individuals with Type 1 Diabetes: A Randomized Crossover Trial
Authors
Funding and Sponsorship None.

Abstract
Background
Despite known risks, many individuals with type 1 diabetes (T1D) fast during Ramadan. Local studies have shown that breaking the fast due to hypoglycemia is common during the morning hours; however, the optimal timing of Suhoor (the predawn meal) has not been thoroughly investigated. Current guidelines recommend late Suhoor; however, this does not provide sufficient time for correction in case of insulin overdosing and can lead to breaking the fast in the early hours.
Objective
To compare the risk of hypoglycemia in individuals with T1D fasting during Ramadan between an early Suhoor (90–120 minutes before dawn plus a predawn snack) and a late Suhoor (30 minutes before dawn).
Methods
In this randomized crossover trial, participants with T1D were assigned to either an early or late Suhoor regimen for 1 week, then switched to the other regimen for the second week. Data were collected via questionnaires and flash continuous glucose monitoring (FCGM).
Results
Forty-four patients were enrolled (73.5% female, mean age 25 ± 5.9 years). During early versus late Suhoor, the proportion of individuals who broke their fast due to hypoglycemia was 64.5% versus 58.1% (p = 0.18). Most hypoglycemia episodes occurred during early fasting hours. Mean fast-breaking days were similar (2.5 vs. 2.05; p = 0.7). FCGM-detected hypoglycemia rates were comparable (5.5 vs. 5.4 events/week; p = 0.65), but hypoglycemia was significantly more frequent in the morning/noon than pre-sunset (1.9 vs. 0.43 events; p < 0.001). The ambulatory glucose profiles of the early versus late regimens were glucose management indicator: 7.58 ± 1.01 versus 7.49 ± 0.9 (p = 0.36), time in range (70–180 mg/dL) of 46.9 ± 17.3% versus 47.9 ± 17.3% (p = 0.99), time below range (<70 mg/dL) of 8.6 ± 14.3% versus 7.8 ± 7.6% (p = 0.15), time above range (>180 mg/dL) of 45.8 ± 22.03% versus 44.5 ± 20.1% (p = 0.6), and glucose variability of 39.3 ± 10.5% versus 40.6 ± 6.5% (p = 0.005).
Conclusion
Adjusting Suhoor timing was well tolerated and offered flexibility. Further research is needed to optimize fasting strategies for individuals with T1D.
Author Contribution
All named authors participated in the conception, planning, and conduct of the study; drafting and revision of the manuscript; and approval of its final version.
Compliance with Ethical Principles
The trial protocol was approved by the Research Office of King Abdulaziz International Medical Research Center (IRBC/0517/21). All participants provided written informed consent. ClinicalTrials.gov: NCT04864483.
Publikationsverlauf
Artikel online veröffentlicht:
17. Oktober 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- 
            References
- 1 Hassanein M, Afandi B, Yakoob Ahmedani M. et al. Diabetes and Ramadan: practical guidelines 2021. Diabetes Res Clin Pract 2022; 185: 109185
- 2 Salti I, Bénard E, Detournay B. et al; EPIDIAR study group. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004; 27 (10) 2306-2311
- 3 Alassiri M. [@MisharyAlassiri]. During Ramadan, which time of the day did you have to break your fast the most [Tweet]? Twitter. 2020 November 2. Accessed September 5, 2022 at: https://twitter.com/MisharyAlassiri/status/1323222616560328705
- 4 Alamoudi R, Alsubaiee M, Alqarni A. et al. Comparison of insulin pump therapy and multiple daily injections insulin regimen in patients with type 1 diabetes during Ramadan fasting. Diabetes Technol Ther 2017; 19 (06) 349-354
- 5 Alamoudi R, Khogeer GS, Qarni AA. et al. Glargine timing during fasting Ramadan in patients with type 1 diabetes: a randomized controlled trial. Diabetes 2021; 70 (Suppl. 01) 152-OR
- 6 Alamoudi RM, Aljohani NJ, Alfadhli EM. et al. Fasting Ramadan in patients with T1DM - Saudi Arabia versus other countries during the COVID-19 pandemic. Diabetes Metab Syndr 2023; 17 (01) 102676
- 7 Garson GD. Testing Statistical Assumptions. Asheboro, NC: Statistical Associates Publishing; 2012
- 8 Alamoudi R, Alsubaiee M, Alqarni A. et al. Attitudes and habits of patients with type 1 diabetes during fasting Ramadan. J Clin Transl Endocrinol 2018; 14: 1-4
- 9 Al-Khawari M, Al-Ruwayeh A, Al-Doub K, Allgrove J. Adolescents on basal-bolus insulin can fast during Ramadan. Pediatr Diabetes 2010; 11 (02) 96-100
- 10 Zabeen B, Tayyeb S, Benarjee B. et al. Fasting during Ramadan in adolescents with diabetes. Indian J Endocrinol Metab 2014; 18 (01) 44-47
- 11 Akram J, De Verga V. Ramadan Study Group. Insulin lispro (Lys(B28), Pro(B29) in the treatment of diabetes during the fasting month of Ramadan. Diabet Med 1999; 16 (10) 861-866
- 12 Ibrahim M, Abu Al Magd M, Annabi FA. et al. Recommendations for management of diabetes during Ramadan: update 2015. BMJ Open Diabetes Res Care 2015; 3 (01) e000108
- 13 Kassem HS, Zantout MS, Azar ST. Insulin therapy during Ramadan fast for Type 1 diabetes patients. J Endocrinol Invest 2005; 28 (09) 802-805
- 14 Kobeissy A, Zantout MS, Azar ST. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan. Clin Ther 2008; 30 (08) 1408-1415
- 15 Mucha GT, Merkel S, Thomas W, Bantle JP. Fasting and insulin glargine in individuals with type 1 diabetes. Diabetes Care 2004; 27 (05) 1209-1210
- 16 Alawadi F, Alsaeed M, Bachet F. et al. Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus. Diabetes Res Clin Pract 2020; 169: 108466
- 17 Afandi B, Kaplan W, Majd L, Roubi S. Rate, timing, and severity of hypoglycemia in adolescents with type 1 diabetes during Ramadan fasting: a study with freestyle libre flash glucose monitoring system. Ibnosina J Med Biomed Sci 2018; 10 (01) 9-11
- 18 Afandi B, Kaplan W, Al Hassani N, Hadi S, Mohamed A. Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes. J Endocrinol Invest 2017; 40 (07) 741-744
- 19 Al-Agha AE, Kafi SE, Zain Aldeen AM, Khadwardi RH. Flash glucose monitoring system may benefit children and adolescents with type 1 diabetes during fasting at Ramadan. Saudi Med J 2017; 38 (04) 366-371
- 20 Al Awadi FF, Echtay A, Al Arouj M. et al. Patterns of diabetes care among people with type 1 diabetes during Ramadan: an international prospective study (DAR-MENA T1DM). Adv Ther 2020; 37 (04) 1550-1563
- 21 Rashid F, Abdelgadir E, Bashier A. A systematic review on the safety of Ramadan fasting in high-risk patients with Diabetes. Diabetes Res Clin Pract 2020; 164: 108161
 
     
      
         
      
    